Copyright
©The Author(s) 2016.
World J Nephrol. Jul 6, 2016; 5(4): 339-357
Published online Jul 6, 2016. doi: 10.5527/wjn.v5.i4.339
Published online Jul 6, 2016. doi: 10.5527/wjn.v5.i4.339
Figure 9 Western blotting for RelB and inhibitor of κB proteins in Lewis and Lewis polycystic kidney.
Immunoblotting was performed for (A) nuclear RelB, and (B) cytoplasmic IκBα, in Lewis and LPK kidney tissue from weeks 3, 10 and 20. Densitometry of immunoblots was quantified for (C) RelB and (D) IκBα. aP < 0.05 vs Lewis for the corresponding timepoint; bP < 0.01 vs Lewis for the corresponding timepoint. LPK: Lewis polycystic kidney; IκBα: Inhibitor of kappa B.
- Citation: Ta MHT, Schwensen KG, Liuwantara D, Huso DL, Watnick T, Rangan GK. Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats. World J Nephrol 2016; 5(4): 339-357
- URL: https://www.wjgnet.com/2220-6124/full/v5/i4/339.htm
- DOI: https://dx.doi.org/10.5527/wjn.v5.i4.339